Company Filing History:
Years Active: 2011
Title: Innovations in Cancer Treatment by Katherine Sixt
Introduction
Katherine Sixt is a prominent inventor based in Baltimore, MD, known for her significant contributions to cancer research. She has developed innovative methods for regulating cell survival, which have the potential to lead to new anti-cancer drugs. Her work focuses on the intricate mechanisms of cell biology and the development of therapeutic agents.
Latest Patents
Katherine Sixt holds a patent titled "Regulation of cell survival by HSP90 and IP6K2." This patent outlines a method for identifying anti-cancer drugs by screening for agents and compounds that inhibit the binding of HSP90 and IP6K2. The patent details the use of in vitro and in vivo assays to monitor various phenomena associated with binding or inhibition, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
Career Highlights
Katherine Sixt is affiliated with The Johns Hopkins University, where she conducts her research and develops her innovative ideas. Her work has garnered attention in the scientific community for its potential impact on cancer treatment and drug development.
Collaborations
Katherine has collaborated with notable researchers such as Solomon H. Snyder and Anutosh Chakraborty. These collaborations have enriched her research and contributed to the advancement of knowledge in the field of cancer biology.
Conclusion
Katherine Sixt's innovative work in cancer research exemplifies the critical role of inventors in developing new therapeutic strategies. Her patent on regulating cell survival highlights the potential for significant advancements in anti-cancer drug development.